We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allergan plc | NYSE:AGN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 193.02 | 0 | 01:00:00 |
TIDM0QCV TIDM0Y7T FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) State Street Global Advisors & Affiliates --------------------------------------------- ------------------------------- Company dealt in AbbVie Inc. --------------------------------------------- ------------------------------- Class of relevant security to which US$0.01 common stock the dealings being disclosed relate (Note 2) --------------------------------------------- ------------------------------- Date of dealing 26(th) November 2019 --------------------------------------------- ------------------------------- 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short ------------------------------------- -------------------- ----------- Number (%) Number (%) ------------------------------------- ---------- -------- ------ --- (1) Relevant securities 67,992,525 4.59762% ------------------------------------- ---------- -------- ------ --- (2) Derivatives (other than options) N/A ------------------------------------- ---------- -------- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------- ---------- -------- ------ --- Total 67,992,525 4.59762% ------------------------------------- ---------- -------- ------ --- (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short ------------------------------------------- ----------- ----------- Number (%) Number (%) ------------------------------------------- ------ --- ------ --- (1) Relevant securities N/A ------------------------------------------- ------ --- ------ --- (2) Derivatives (other than options) N/A ------------------------------------------- ------ --- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------------- ------ --- ------ --- Total N/A ------------------------------------------- ------ --- ------ --- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) -------------- ----------------------------- ----------------------- Purchase 3,300 87.72 -------------- ----------------------------- ----------------------- Purchase 100 87.72 -------------- ----------------------------- ----------------------- Purchase 300 87.72 -------------- ----------------------------- ----------------------- Purchase 1,500 87.65 -------------- ----------------------------- ----------------------- Purchase 700 87.72 -------------- ----------------------------- ----------------------- Purchase 600 87.71 -------------- ----------------------------- ----------------------- Purchase 400 87.72 -------------- ----------------------------- ----------------------- Purchase 759 87.72 -------------- ----------------------------- ----------------------- Purchase 1,400 87.72 -------------- ----------------------------- ----------------------- Purchase 1,700 87.72 -------------- ----------------------------- ----------------------- Purchase 600 87.71 -------------- ----------------------------- ----------------------- Purchase 1,100 87.71 -------------- ----------------------------- ----------------------- Purchase 700 87.71 -------------- ----------------------------- ----------------------- Purchase 15,700 87.72 -------------- ----------------------------- ----------------------- Purchase 24,100 87.72 -------------- ----------------------------- ----------------------- Purchase 1,400 87.72 -------------- ----------------------------- ----------------------- Purchase 53,600 87.72 -------------- ----------------------------- ----------------------- Purchase 2,800 87.60 -------------- ----------------------------- ----------------------- Purchase 4,000 87.72 -------------- ----------------------------- ----------------------- Purchase 700 87.72 -------------- ----------------------------- ----------------------- Purchase 1,200 87.75 -------------- ----------------------------- ----------------------- Purchase 200 87.72 -------------- ----------------------------- ----------------------- Purchase 140 87.72 -------------- ----------------------------- ----------------------- Purchase 48,048 87.72 -------------- ----------------------------- ----------------------- Purchase 12,012 87.72 -------------- ----------------------------- ----------------------- Purchase 452 87.72 -------------- ----------------------------- ----------------------- Purchase 1,940 87.72 -------------- ----------------------------- ----------------------- Purchase 90 87.72 -------------- ----------------------------- ----------------------- Purchase 100 87.72 -------------- ----------------------------- ----------------------- Purchase 160 87.72 -------------- ----------------------------- ----------------------- Purchase 1,100 87.72 -------------- ----------------------------- ----------------------- Purchase 900 87.72 -------------- ----------------------------- ----------------------- Purchase 400.00 87.55 -------------- ----------------------------- ----------------------- Purchase 500.00 87.71 -------------- ----------------------------- ----------------------- Purchase 1115.00 87.72 -------------- ----------------------------- ----------------------- Purchase 1072.00 87.72 -------------- ----------------------------- ----------------------- Sale 500 87.24 -------------- ----------------------------- ----------------------- Sale 1,300 87.68 -------------- ----------------------------- ----------------------- Sale 93 87.72 -------------- ----------------------------- ----------------------- Sale 24,100 87.72 -------------- ----------------------------- ----------------------- Sale 15,700 87.72 -------------- ----------------------------- ----------------------- Sale 372 87.63 -------------- ----------------------------- ----------------------- Sale 200 87.72 -------------- ----------------------------- ----------------------- Sale 900 87.72 -------------- ----------------------------- ----------------------- Sale 1,400 87.72 -------------- ----------------------------- ----------------------- Sale 1,400 87.72 -------------- ----------------------------- ----------------------- Sale 700 87.72 -------------- ----------------------------- ----------------------- Sale 400 87.72 -------------- ----------------------------- ----------------------- Sale 100 87.72 -------------- ----------------------------- -----------------------
Sale 17,740 87.72 -------------- ----------------------------- ----------------------- Sale 297 87.72 -------------- ----------------------------- ----------------------- Sale 5,820 87.72 -------------- ----------------------------- ----------------------- Sale 3,224 87.72 -------------- ----------------------------- ----------------------- Sale 260 87.65 -------------- ----------------------------- ----------------------- Sale 259 87.65 -------------- ----------------------------- ----------------------- Sale 100 87.72 -------------- ----------------------------- ----------------------- Sale 700 87.72 -------------- ----------------------------- ----------------------- Sale 5,209 87.65 -------------- ----------------------------- ----------------------- Sale 400 87.72 -------------- ----------------------------- ----------------------- Sale 300 86.90 -------------- ----------------------------- ----------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) ------------- --------------------- ----------------------------- -------------- N/A ------------- --------------------- ----------------------------- -------------- (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money e.g. call option purchasing securities to which price American, date paid/received varying etc. the option relates European etc. per unit (Note 5) (Note 7) ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ N/A ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ (ii) Exercising Product name, Number of securities Exercise price per e.g. call option unit (Note 5) ----------------- -------------------- ------------------ N/A ----------------- -------------------- ------------------ (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) --------------------- ------- ------------------------- N/A --------------------- ------- ------------------------- 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ----------------------------------------------------------- N/A ----------------------------------------------------------- Is a Supplemental Form 8 attached? (Note 9) NO ------------------------------------------------------- -------------------- Date of disclosure 27(th) November 2019 ------------------------------------------------------- -------------------- Contact name Lionel Colaco ------------------------------------------------------- -------------------- Telephone number 020 33956098 ------------------------------------------------------- -------------------- If a connected EFM, name of offeree/offeror with which N/A connected ------------------------------------------------------- -------------------- If a connected EFM, state nature of connection (Note N/A 10) ------------------------------------------------------- --------------------
(END) Dow Jones Newswires
November 27, 2019 09:44 ET (14:44 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions